4.3 Article Proceedings Paper

eIF4E, the mRNA cap-binding protein: from basic discovery to translational research

Related references

Note: Only part of the references are listed.
Review Neurosciences

Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function

Carla Garza-Lombo et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2016)

Review Oncology

Deregulation of the Akt pathway in human cancer

Eriko Tokunaga et al.

CURRENT CANCER DRUG TARGETS (2008)

Article Medicine, Research & Experimental

Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity

Jeremy R. Graff et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Medicine, Research & Experimental

Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2

Olivier Le Bacquer et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Review Biochemistry & Molecular Biology

mTOR and cancer therapy

J. B. Easton et al.

ONCOGENE (2006)

Review Oncology

mTOR signaling: implications for cancer and anticancer therapy

E Petroulakis et al.

BRITISH JOURNAL OF CANCER (2006)

Article Multidisciplinary Sciences

IRF-7 is the master regulator of type-I interferon-dependent immune responses

K Honda et al.

NATURE (2005)

Article Multidisciplinary Sciences

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

HG Wendel et al.

NATURE (2004)

Review Cell Biology

Upstream and downstream of mTOR

N Hay et al.

GENES & DEVELOPMENT (2004)

Article Biochemistry & Molecular Biology

The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

D Ruggero et al.

NATURE MEDICINE (2004)

Review Oncology

Does the ribosome translate cancer?

D Ruggero et al.

NATURE REVIEWS CANCER (2003)

Review Cell Biology

Regulation of translation initiation by FRAP/mTOR

AC Gingras et al.

GENES & DEVELOPMENT (2001)